|
|
 |
|
Group to re-file suit over Glaxo HIV drug patents Yahoo! News The AIDS Healthcare Foundation (AHF) said on Monday that it will re-file its legal challenge to GlaxoSmithKline Plc's patents on the HIV treatments Combivir (lamivudine, zidovudine) and Trizivir (zidovudine, lamivudine, abacavir), as well as the drugs' key ingredient AZT.
—Posted: March 26, 2003
More news headlines: This week | Last week | Search archive
|
|
|
